Antimicrobial Stewardship and Antimicrobial Resistance Mechanisms Flashcards

1
Q

describe the role of veterinarians in public health

A
  1. goal: reduce the need for antimicrobial use (AMU)
  2. keep animals healthy:
    -preventative medicine
    -biosecurity practices
    -properly disinfect equipment
  3. keep ourselves, workers, and animals owners healthy
    -hand hygiene
    -PPE
  4. safely dispose of unused antimicrobials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when is antimicrobial use indicated?

A
  1. when inhibiting growth or killing of bacteria will allow treatment or prevention of infection
  2. clinical scenarios:
    -prevention: at risk animals (severe immune compromise, peri-operative, high-risk cattle); targeted metaphylaxis

-treatment: sick animal (confirmed or suspected bacterial disease associated with a specific pathogen)

  1. minimum additional requirements:
    -rest
    -nursing care
    -adequate nutrition
    -immune function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 5 rights of antimicrobial stewardship?

A
  1. right drug
  2. right dose
  3. right time
  4. right duration
  5. right route of administration

de-escalation/refine: target the pathogen based on culture and susceptibility results AND patient response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some considerations for AMU?

A
  1. VCPR
  2. species
  3. site of infection
  4. pathogen
  5. route of admin
  6. comorbidities
  7. side effects
  8. owner compliance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the tiers of antimicrobial stewardship programs

A

tier 1: prevention, peri-op, first line

tier 2: use if C&S of MIC indicates tier 1 won’t be effective; not responding to tier 1, or disease pathogen or process (sepsis) dictates used of a higher tier drug (rhodococcus equi in foals)

US FDA/USDA:
restricted: no extralabel drug use (ELDU) with cephalosporins for food producing species

prohibited: no use (illegal)

rule of thumb: prescribe like there is an ASP (antimicrobial stewardship program) even if there isn’t an established program in your practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe absorption, metabolism, and excretion

A

absorption/bioavailability:
-IV = 100% bioavailable
-other routes have reduced and variable bioavailability (especially oral and per rectum)

metabolism: drug is either metabolized or excreted unchanged
-some drugs have active metabolites

excretion:
-glomerular filtration
-renal tubular secretion
-hepatic metabolism and/or biliary excretion
-mixed renal and hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe distribution

A
  1. polar: hydrophilic and remain in the water compartments of tissue (plasma, extracellular fluid)
  2. lipophilic: penetrate into the tissues and are able to pass through lipid bilayer
    -high volume of distribution
  3. protein-binding: carried around on protein, which makes the half-life longer and can act as a reservoir/depot
    -free drug is active drug; protein binding, pH of local environment, and purulent material in local environment can influence amount of free drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe opportunistic commensal bacteria by body location

A
  1. respiratory:
    -streptococcus
    -staphyloccocus
    -pasteurellacea
    -actinobacillus
  2. skin:
    -gram positive cocci: staph and strep
  3. genitourinary tract:
    -ascending infections: combo of skin and GI tract flora (gram positive and negative aerobes)
  4. GI tract:
    -gram negative enteric bacteria
    -gram positive cellulolytic bacteria
    -anaerobes
  5. oral cavity:
    -anaerobes (prevotella)
    -facultative anaerobes
    -pasteurellacea
    -actinobacillus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe privileged sites

A
  1. CNS (BBB)
  2. prostate (BPB)
  3. eye (BOB)

difficult to reach: bone, abscesses

in these sites: lipophilic drugs rule and polar drugs drool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do the antimicrobials we give impact human health?

A
  1. direct contact
  2. the environment
  3. the food chain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe risk factors for recovering a resistant isolate from veterinary patients

A
  1. current or prior antimicrobial exposure
    -alteration in the microbiome (GI, skin, etc.)
  2. environment
  3. contact with humans
    -horses with MRSA
  4. healthcare associated infections
  5. food exposure (raw diets)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe campylobacteriosis

A
  1. campylobacter jejuni
    -asymptomatic: self limiting in most
    -puppies with disease: not a problem when with mom but can see when moving to different facilities and co-mingling
  2. emergence of drug resistance campylobacter from just blasting these pups with antimicrobials (#fuckpetland)
    -puppy to human transmission now also possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

contrast antimicrobial resistance to inherent/intrinsic resistance

A

antimicrobial resistance: a characteristic a microorganism has develop in response to antimicrobial pressure

inherent/intrinsic resistance: an inherent feature of a microorganism that makes it susceptible to an antimicrobial drug
-the drug never worked on that organism because of some structural or functional difference
-ex.) enterococcus can absorb folate from environment, so are resistant to TMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how are mechanisms of resistance transferred

A
  1. horizontal gene transfer: multiple mechanisms
    -conjugation: cell to cell transfer
    -transduction: transfer from a bacteriophage (virus)
    -transformation: absorption from environment
  2. mobile genetic elements: plasmids, transposons, integrative and conjugative elements (ICEs)
    -can carry resistance to multiple drug classes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe the mutant selection window

A
  1. exposing bacteria to antimicrobial pressure that favors gene mutations achieving a concentration above MIC and below MPC (mutant prevention concentration)
    -sometimes parameters for how above MIC you need to be are based on the MPC
  2. kills the weak and favors the strong
  3. DOES NOT UNIVERSALLY KNOCK OUT ALL ISOLATES; leaves the really strong ones behind
  4. in a bacterial infection, growth and rapid replication of genetic material allows plenty of opportunities for “fortunate mistakes”/mutations that favor resistance and survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

once we have antimicrobial resistant bugs in the patient will they be there forever?

A
  1. once antimicrobial selection pressure is removed, wild type phenotypes re-emerge rapidly for some bacterial isolates within days
  2. bacteria will retain the antimicrobial resistance phenotype if there is a fitness advantage
17
Q

are antimicrobial resistant organisms more pathogenic?

A
  1. generally no
  2. patient: infection is not more severe and organisms are not more virulent than wild-type strains
  3. environment: expected to respond to rigorous cleaning and disinfection similar to wild-type strain
18
Q

describe antimicrobial susceptibility testing

A
  1. ID a source of infection and obtain proper sample
  2. submit for both cytology and culture
  3. from isolates, run disk diffusion via Kirby bauer method: MIC based on zone of inhibition; the smaller the zone the greater the MIC
  4. microdilution broth: MIC based on OD/visible growth
19
Q

describe antimicrobial susceptibility results

A
  1. based on clinical and laboratory standards institute (CLSI) which helped make veterinary breakpoints
  2. veterinary breakpoints: for limited pathogens and veterinary species
    -PK/PD dynamic data derived from studies of healthy animals/humans
    -MIC of pathogen from in vitro data
    -prospective clinical studies (rare in vet med)
  3. reported as:
    -susceptible
    -intermediate
    -resistant
    -and give numeric MIC